Last updated: September 19, 2023
Sponsor: Cairo University
Overall Status: Active - Recruiting
Phase
1/2
Condition
Impotence
Male Hormonal Deficiencies/abnormalities
Infertility
Treatment
Injection of Botulinum neurotoxin (BoNT)
Penile duplex and shear wave elastosonography (SWE).
Clinical Study ID
NCT06044883
MS-191-2023
Ages 18-70 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Men with ED not responding to oral PDE5Is.
Exclusion
Exclusion Criteria:
- Patients with penile prostheses.
- Patients diagnosed with Peyronie's disease.
- Non-vascular erectile dysfunction.
- Medical comorbidities that would limit the benefit of ICI such as uncontrolleddiabetes mellitus, significant cardiovascular disease interfering with sexualactivity, unstable psychiatric conditions, and the presence of anatomical, hormonal,or neurological abnormalities that would significantly impair erectile function.
- Patients with a history of radical pelvic surgery.
- Pelvic or spinal trauma
Study Design
Total Participants: 32
Treatment Group(s): 2
Primary Treatment: Injection of Botulinum neurotoxin (BoNT)
Phase: 1/2
Study Start date:
June 01, 2023
Estimated Completion Date:
January 01, 2024
Connect with a study center
Faculty of Medicine, Cairo University
Cairo,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.